Why 17% of Your Patients Feel ‘Difficult’ and How to Respond Providers frequently face challenging clinical … Why 17% of Your Patients Feel ‘Difficult’ and How to RespondRead more
Internal Medicine
New Model Refines Prostate Cancer Mortality Risk After PSA
The long-term challenge in prostate-specific antigen (PSA) screening involves accurately predicting which patients face the highest … New Model Refines Prostate Cancer Mortality Risk After PSARead more
Functional Dyspepsia: Essential Guide for Clinicians
Functional Dyspepsia (FD) is a common, chronic, and potentially serious medical syndrome. Consequently, clinicians must understand … Functional Dyspepsia: Essential Guide for CliniciansRead more
Do Not Wait: Give the Flu Shot Before Heart Failure Discharge
A recent landmark study confirms a vital clinical strategy for heart failure (HF) management. Specifically, providing … Do Not Wait: Give the Flu Shot Before Heart Failure DischargeRead more
A Simple Way to Slash Ventricular Arrhythmia Risk Now
The POTCAST trial established a significant new strategy for managing patients at high risk for ventricular … A Simple Way to Slash Ventricular Arrhythmia Risk NowRead more
SGLT-2is vs. GLP-1RAs: Which Drug Lowers Diabetic Foot Risk?
An emulated target trial examined the comparative effectiveness of two major drug classes for type 2 … SGLT-2is vs. GLP-1RAs: Which Drug Lowers Diabetic Foot Risk?Read more
Major Update: Digitoxin Cuts HFrEF Risk by 18% in Landmark Trial
The results of the pivotal DIGIT-HF trial show significant new evidence for a long-used cardiac glycoside. … Major Update: Digitoxin Cuts HFrEF Risk by 18% in Landmark TrialRead more
Breakthrough in High-Risk Myeloma: New Dual-Targeting Data
Relapsed or refractory multiple myeloma (RRMM) is difficult to treat, but true Extramedullary Myeloma (EMM) presents … Breakthrough in High-Risk Myeloma: New Dual-Targeting DataRead more
Tividenofusp Alfa: New Hope for Brain-Penetrant MPS II Therapy
Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a progressive, devastating lysosomal storage … Tividenofusp Alfa: New Hope for Brain-Penetrant MPS II TherapyRead more
High Mortality in Cardiogenic Shock: New Treatment Avenues
Cardiogenic shock involves a severe depression of cardiac function. This critical condition leads to dangerously low … High Mortality in Cardiogenic Shock: New Treatment AvenuesRead more
